Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze KALV stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate KALV investment potential.

What is KALV stock price today?

Get real-time KALV stock price, historical data, and price charts on Financhill. Track KALV performance with our advanced analysis tools.

Is KALV a good investment?

Evaluate KALV investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy KALV stock?

To buy KALV stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of KALV?

View detailed market capitalization data and company valuation metrics for KALV on our comprehensive analysis page.

What is the P/E ratio of KALV?

Use our fundamental analysis tools to view KALV P/E ratio and compare valuation metrics with industry peers.

What are KALV earnings?

View KALV earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

KalVista Pharmaceuticals, Inc. Stock Predictions

AI Powerhouse Raises Price - But Room Remains

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Buy

KALV
KalVista Pharmaceuticals, Inc.

Last Price:

$16.41

Seasonality Move:

6.97%

7 Day Trial

ALL ACCESS PASS

$ 7

This AI Layer Just Raised Its Share Price

KalVista Pharmaceuticals, Inc. Stock Forecast

Over the next 52 weeks, KalVista Pharmaceuticals, Inc. has on average historically risen by 11.6% based on the past 10 years of stock performance.
KalVista Pharmaceuticals, Inc. has risen higher in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Is KalVista Pharmaceuticals, Inc. Stock Undervalued?

The current KalVista Pharmaceuticals, Inc. [KALV] share price is $14.66. The Score for KALV is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
KALV is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will KalVista Pharmaceuticals, Inc. Stock Go Up Next Year?

Over the next 52 weeks, KalVista Pharmaceuticals, Inc. has on average historically risen by 11.6% based on the past 10 years of stock performance.

KalVista Pharmaceuticals, Inc. Stock Rating

Buy

KalVista Pharmaceuticals, Inc. (KALV) is a Buy

Is KalVista Pharmaceuticals, Inc. overpriced?

KalVista Pharmaceuticals, Inc. has risen higher in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%

KalVista Pharmaceuticals, Inc. Stock Price History

Is KALV stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KALV is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

kalvista.com

52-Week Data

52-Week High:

17.28

52-Week Low:

7.30

Prediction Charts

Market Cap:

741M

Price in USD:

14.66

Volume:

6.4M

Beta:

1.10

Technical Analysis

SMA50:

12.11

SMA100:

13.01

SMA200:

12.62

52-Wk Change:

50.67%

Stock Predictions

Is KalVista Pharmaceuticals, Inc. stock public?

Yes, KalVista Pharmaceuticals, Inc. is a publicly traded company.
What is the KalVista Pharmaceuticals, Inc. stock quote today?

The KalVista Pharmaceuticals, Inc. stock price is 14.66 USD today.
How to buy KalVista Pharmaceuticals, Inc. stock online?

You can buy KalVista Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Nov-14	13.13	13.62	13.87	12.95
Nov-17	13.48	14.86	14.97	13.32
Nov-18	14.75	14.27	14.79	14.06
Nov-19	14.01	13.71	14.49	13.68
Nov-20	13.83	13.02	14.19	13.01
Nov-21	12.97	13.10	13.67	12.82
Nov-24	13.12	13.36	13.75	13.06
Nov-25	13.45	13.28	13.52	13.13
Nov-26	13.35	14.10	14.41	13.19
Nov-28	14.11	14.47	14.51	14.03
Dec-1	14.23	13.92	14.31	13.45
Dec-2	13.92	13.52	13.94	13.28
Dec-3	13.64	14.66	16.49	13.37
Dec-4	14.63	16.40	16.80	14.30

KalVista Pharmaceuticals, Inc. Earnings

KalVista Pharmaceuticals, Inc. Earnings Report: Per Share KalVista Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

KalVista Pharmaceuticals, Inc. Forecast Revenue Growth

KalVista Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for KalVista Pharmaceuticals, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.70 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.01 per share, and an increase next year of $1.02 per share.

* KalVista Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.